This Week in HIV Research: A New Frontier in Organ Transplantation

This Week in HIV Research: A New Frontier in Organ Transplantation

1 of 5
Next >

As the seasons begin to noticeably turn throughout much of the world, the gears of our communal HIV research machine keep inexorably grinding. Among the recently published studies with the potential to impact HIV care, this week we see:

  • A first in liver transplantation: an HIV-positive donor and an HIV-negative recipient.
  • New data showing the degradation of the continuum of care for formerly incarcerated people in the U.S.
  • Signs that reduced bone mineral density is a complication that extends to men with HIV under the age of 50, despite viral suppression (and regardless of tenofovir disoproxil fumarate use).
  • Discouraging findings regarding the (lack of) anti-inflammatory effects of an antiplatelet agent for people with HIV.

Let's take a deeper look at each of these studies together. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: photographereddie via iStockphoto

As the seasons begin to noticeably turn throughout much of the world, the gears of our communal HIV research machine keep inexorably grinding. Among the recently published studies with the potential to impact HIV care, this week we see:

  • A first in liver transplantation: an HIV-positive donor and an HIV-negative recipient.
  • New data showing the degradation of the continuum of care for formerly incarcerated people in the U.S.
  • Signs that reduced bone mineral density is a complication that extends to men with HIV under the age of 50, despite viral suppression (and regardless of tenofovir disoproxil fumarate use).
  • Discouraging findings regarding the (lack of) anti-inflammatory effects of an antiplatelet agent for people with HIV.

Let's take a deeper look at each of these studies together. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: photographereddie via iStockphoto